Rare genitourinary malignancies remain a diverse and often challenging subset of tumor types for clinicians to care for. There are a number of reasons for the resulting challenges imparted in caring for these patients including the infrequent number of cases cared for within large healthcare systems as well as the paucity of prospective studies aimed at redefining the treatment standards for these poorly funded malignancies attracting limited industry support. This series highlights exciting advances which have been made in caring for many of these tumors and encompass the topics of adrenocortical carcinoma, extra-gonadal germ cell, melanoma, penile, sarcoma, scrotal, and urethral cancers.

Disclosure:
The series “Rare Genitourinary Malignancies” was commissioned by the editorial office, AME Medical Journal without any sponsorship or funding. Philippe E. Spiess served as the unpaid Guest Editor for the series.